Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE

https://doi.org/10.20996/1819-6446-2016-12-6-631-637

Full Text:

Abstract

Aim. Expert assessment of real clinical practice compliance with national guidelines on management of patients with chronic heart failure (HF) before the opening of the Expert Center of HF treatment.

Material and methods. All patients admitted to 2 city clinical hospitals of Moscow with HF were included into the register. Clinical, demographic, laboratory and instrumental characteristics and medical treatment before and during hospitalization were evaluated, as well as recommendations contained in the discharge summary.

Results. 300 patients with HF were included into the register. The mean age was 75 years (39, 95); the proportion of men – 44%. 95% of patients had HF IIIV (NYHA), among them 24% HF II, 61% HF III, 15% HF IV (NYHA). HF with reduced ejection fraction (HFrEF) was found in 45% of patients. 22% of the patients did not receive medical treatment before admission. 34% of patients with HFrEF received ACE inhibitors/angiotensin receptor blockers (ARBs), of which only 23% in effective dose. β-blockers were prescribed in 41% of HFeEF patients, of which 22% in the target dose. A third of patients needed in mineralocorticoid receptor antagonists (MRA) received spironolactone. During hospitalization 81% of HFrEF patients received ACEI therapy, 12% – ARBs, 91% – β-blockers, 90% – MRA, 81% – loop diuretics and 13% – thiazide diuretics. According to the discharge summary 5% of patients did not receive post-discharge blocker of the renin-angiotensin-aldosterone system without explanation in the medical documentation. β-blocker with proven efficacy was prescribed to 70% of HFrEF patients. Spironolactone was recommended after discharge in 89% of HFrEF patients.

Conclusion. Implementation of register of hospitalized patients with HF gives an opportunity to identify shortcomings in the provision of medical care both in outpatient and inpatient stages. 

About the Authors

E. K. Shavarova
Peoples’ Friendship University of Russia
Russian Federation

Elena K. Shavarova – MD, PhD, Associate Professor, Chair of Propedeutics of Internal Diseases.

Miklukho-Maklaya ul. 6, Moscow, 117198 Diseases



L. A. Babaeva
Peoples’ Friendship University of Russia
Russian Federation
Lala A. Babaeva – MD, PhD, Associate Professor, Chair of Propedeutics of Internal Diseases


S. S. Padaryan
Peoples’ Friendship University of Russia
Russian Federation
Sergey S. Padaryan – MD, PhD, Assistant, Chair of Propedeutics of Internal Diseases s


N. N. Soseliya
Peoples’ Friendship University of Russia
Russian Federation
Nino N. Soseliya – MD, Fellow, Chair of Propedeutics of Internal Diseases s


O. I. Lukina
Peoples’ Friendship University of Russia
Russian Federation
Olga I. Lukina – MD, Fellow, Chair of Propedeutics of Internal Diseases


A. S. Milto
Peoples’ Friendship University of Russia; Moscow City Clinical Hospital №64
Russian Federation

Anna S. Milto – MD, PhD, Professor, Chair of Propedeutics of Internal Diseases, Peoples’ Friendship University of Russia; Deputy Medical Director in Charge of Medicine, City Clinical Hospital № 64



References

1. Belenkov Yu.N., Fomin I.V., Mareev V.Yu. et al. The first results of the Russian epidemiological studies on heart failure. Serdechnaya Nedostatochnost '. 2003;4(1):26-30. (In Russ.) [Беленков Ю. Н., Фомин И. В., Мареев В. Ю. и др. Первые результаты Российского эпидемиологического исследования по ХСН. Сердечная Недостаточность. 2003;4(1):26-30].

2. Ageev F.T., Danielyan M.O., Mareev V.Yu., et al. Patients with chronic heart failure in the Russian ambulatory practice: particular contingent, diagnosis and treatment (studies AGE-O-CHF). Serdechnaya Nedostatochnost'. 2004;5(1):4-7. (In Russ.) [Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА-О-ХСН). Сердечная Недостаточность. 2004;5(1):4-7].

3. Ageev F.T., Belenkov Yu.N., Fomin I.V., et al. The prevalence of chronic heart failure in the European part of the Russian Federation -Data of EPOHA-HSN study. Serdechnaya Nedostatochnost'. 2006;7(1):1125. (In Russ.) [Агеев Ф. Т., Беленков Ю.Н., Фомин И. В. и др. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации – данные ЭПОХА-ХСН. Сердечная Недостаточность. 2006;7 (1):112-5].

4. Lloyd-Jones D., Adams R., Carnethonet M. et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-181.

5. Kosiborod M., Lichtman J.H., Heidenreich P.A. et al. National trends in outcomes among elderly patients with heart failure. Am J Med. 2006;119(7):616 e1-7.

6. Stewart S. Financial aspects of heart failure programs of care. Eur J Heart Fail. 2005;7: 423-428.

7. (InRuss.) [Национальные рекомендации по диагностикеи лечению ХСН.СердечнаяНедостаточность. 2013;14(7):1-81].

8. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The task force for the diagnosis and the treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.

9. Van der Wal M.H., Jaarsma T., van Veldhuisen D.J. Non-compliance in patients with heart failure: how can we manage it? Eur J Heart Fail. 2005;1(7):5-17.

10. Rich M.W., Beckham V., Wittenberg C. et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-5.

11. McAlister F.A., Stewart S., Ferrua S. Et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44:810-9.

12. Göhler A.,JannuzziJ.L., Worrell S.S. et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail. 2006;12(7):554-67.

13. Roccaforte R., Demers C., Baldassarre F. et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail. 2005;7(7):1133-44.

14. Michota Jr F.A., Amin A. Bridging the gap between evidence and practice in acute decompensated heart failure management. J Hosp Med. 2008;3(6 suppl):S7-15.


For citation:


Shavarova E.K., Babaeva L.A., Padaryan S.S., Soseliya N.N., Lukina O.I., Milto A.S. CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 2016;12(6):631-637. (In Russ.) https://doi.org/10.20996/1819-6446-2016-12-6-631-637

Views: 478


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)